Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12258756 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNATSHRHSD17B10SMN1; SMN2 | |
| SCHEMBL18674360 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNATSHRHSD17B10SMN1; SMN2 | |
| SCHEMBL31376279 | 0.91 | ALDH1A1 (0.42) | ALDH1A1LMNATSHRHSD17B10SMN1; SMN2 | |
| SCHEMBL13612953 | 0.81 | ALDH1A1 (0.33) | ALDH1A1LMNA | |
| SCHEMBL721491 | 0.80 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRTDP1 | |
| SCHEMBL24080202 | 0.75 | — | — | |
| SCHEMBL2017195 | 0.75 | ALDH1A1 (0.56) | ALDH1A1LMNATSHRHSD17B10TDP1 | |
| SCHEMBL685153 | 0.75 | — | — | |
| SCHEMBL418078 | 0.75 | — | — | |
| SCHEMBL23875 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624164-B2 | Synthetic thickeners incorporating non-reactive diluents | HERCULES LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-12590181-B2 | Hydrophobically-modified associative thickener polymers process for the preparation and uses thereof | HERCULES LLC (US) | 2026-03-31 | — | — | US | disclosed |
| EP-4192923-B1 | HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF | HERCULES LLC (US) | 2025-10-29 | — | — | EP | disclosed |
| CN-116324123-B | Hydrophobically modified associative thickener polymer and preparation method and application thereof | 赫尔克里士有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-116324124-B | Hydrophobically modified associative thickener polymer and preparation method and application thereof | 赫尔克里士有限公司 | 2025-03-18 | — | — | CN | disclosed |
| US-20230323138-A1 | HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF | HERCULES LLC (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230257522-A1 | HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF | HERCULES LLC (US) | 2023-08-17 | — | — | US | disclosed |
| CN-116324123-A | Hydrophobically modified associative thickener polymer and preparation method and application thereof | 赫尔克里士有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116324124-A | Hydrophobically modified associative thickener polymer and preparation method and application thereof | 赫尔克里士有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4192922-A1 | HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF | Hercules LLC (US) | 2023-06-14 | — | — | EP | disclosed |
| US-20160115175-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2016-04-28 | — | — | US | disclosed |
| US-20160083395-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2016-03-24 | — | — | US | disclosed |
| US-9233974-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2016-01-12 | — | — | US | disclosed |
| US-20150361087-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2015-12-17 | — | — | US | disclosed |
| US-20140316144-A1 | ANTIVIRAL COMPOUNDS | GILEAD PHARMASSET LLC | 2014-10-23 | — | — | US | disclosed |
| US-20140178336-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2014-06-26 | — | — | US | disclosed |
| US-20130309196-A1 | ANTIVIRAL COMPOUNDS | GILEAD PHARMASSET LLC | 2013-11-21 | — | — | US | disclosed |
| US-8586112-B2 | Treatment of parasitic infections in humans and animals | SOUTH AFRICAN MEDICAL RESEARCH COUNCIL (ZA) | 2013-11-19 | — | — | US | disclosed |
| US-20110190300-A1 | AMIDE COMPOUNDS AND THE USE THEREOF | EURO-CELTIQUE S.A. (LU) | 2011-08-04 | — | — | US | disclosed |
| US-20090304832-A1 | Treatment of Parasitic Infections in Humans and Animals | SOUTH AFRICAN MEDICAL RESEARCH COUNCIL (ZA) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130309196-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SARS1 | ALDH1A1 3925/4885LMNA 1463/4885TSHR 4860/4885 |
| US-12624164-B2 | Synthetic thickeners incorporating non-reactive diluents | GEMIN4, MAGT1, SETDB1 | ALDH1A1 2580/4885LMNA 3700/4885TSHR 3556/4885 |
| US-12590181-B2 | Hydrophobically-modified associative thickener polymers process for the preparation and uses thereof | PHOSPHO1, H1-10, H1-0 | ALDH1A1 4014/4885LMNA 2634/4885TSHR 3461/4885 |
| US-20110190300-A1 | AMIDE COMPOUNDS AND THE USE THEREOF | CACNA1E, CACNA1B, CACNA1S | ALDH1A1 1349/4885LMNA 2476/4885TSHR 2852/4885 |
| US-20160115175-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SARS1 | ALDH1A1 3925/4885LMNA 1463/4885TSHR 4860/4885 |
| US-20140178336-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SARS1 | ALDH1A1 3925/4885LMNA 1463/4885TSHR 4860/4885 |
| US-20140316144-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SARS1 | ALDH1A1 3925/4885LMNA 1463/4885TSHR 4860/4885 |
| US-20090304832-A1 | Treatment of Parasitic Infections in Humans and Animals | DPM1, OAT, ICMT | ALDH1A1 1215/4885LMNA 1659/4885TSHR 4352/4885 |
| US-20150361087-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SARS1 | ALDH1A1 3925/4885LMNA 1463/4885TSHR 4860/4885 |
| US-20160083395-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SARS1 | ALDH1A1 3925/4885LMNA 1463/4885TSHR 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.